Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Indices rise and fall as growth, inflation, and risk appetite shift; news and expectations reshape valuation baselines and asset flows.
21,301 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Thinking about retiring in your 40s? The FIRE movement offers a practical path to financial independence through aggr...
A major fund trims a big stake in a tech name, sparking questions about risk, sector exposure, and portfolio resilien...
Cava posted a record year, topping rivals with 2025 revenue of $1.169 billion and 72 new restaurants. The chain signa...
Markets open with caution as AI jitters mix with Middle East tensions. This article breaks down what this means for y...
Two KKR Co-CEOs bought a combined 175,000 shares in February, signaling confidence as the stock trades in the mid-$90...
SolarEdge spearheads a broad solar stock bounce as bond yields retreat, with Enphase Energy and Sunrun posting solid ...
A historic Oscar moment turns into a money lesson. This article uses ejae’s acceptance speech first-ever as a case st...
Despite higher mortgage costs, housing demand still growing remains intact. Weekly data show ongoing buyer interest e...
A rural Louisiana parish is undergoing a dramatic shift as Meta nears completion of a sprawling data center. The proj...
Pinterest sparked a noticeable stock move after its Q1 results, but a single quarter rarely writes the full comeback ...
The April consumer price index rose 0.6% from March, pushing annual inflation to 3.8%. Energy costs led the gain, wit...